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Percutaneous transluminal balloon valvuloplasty was at-
tempted in 92 adult patients with severe calcific aortic
stenosis. The mean age was 75 ± 11 years (range 38 to
91) and 35 patients were more than 80 years old. Most
of the patients were severely disabled; 66 were in New
York Heart Association functional class III or IV, 27
had syncopal attacks and 21 had severe angina pectoris.
Because of unacceptably high surgical risk or contrain-
dication to thoracic surgery, 42 patients could not be
considered for valve replacement. Other patients either
were in a category of high operative risk or refused the
surgical intervention.
Valvuloplasty was performed by way of the femoral
route (82 patients) or the brachial route (10 patients).
Catheters of size 15, 18 and 20 mm were successively
placed across the aortic valve and three inflations were
usually done with each of them, lasting 80 seconds on
average, until a decrease in peak to peak systolic pres-
sure gradient to 40 mm Hg or less was attained, a result
considered satisfactory. The inflated balloons were not
totally occlusive in most cases and clinical tolerance of
inflation was good. Valvuloplasty resulted in a reduction
of mean systolic gradient from 75 ± 26 to 30 ± 13 mm
Hg (p < 0.001); the final gradient was less than 40 mm
Hg in 78 patients. Mean calculated aortic valve area
increased from 0.49 ± 0.17 to 0.93 ± 0.36 cnr' (p <
Over the last few years, percutaneous transluminal angio-
plasty with balloon catheters has become a widely accepted
nonsurgical means of treating stenosis of peripheral vessels
(\ ,2) and coronary arteries (3). The method has also been
used successfully in congenital pulmonary and aortic valve
stenosis in children and young adults (4-11). Recently. a
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0.001). Immediately after the procedure, ejection frac-
tion increased from 48 ± 16 to 51 ± 16% (p < 0.01).
Valvuloplasty generally resulted in a minor increase in
aortic insufficiency, except in two patients in whom it
increased from grade 1 to 3. There was no clinical evi-
dence of embolic phenomena.
The mean hospital stay was 6 days. There were three
in-hospital deaths, two due to complications of arterial
catheterization and one related to insufficient valve di-
lation. A dramatic in-hospital clinical improvement was
noted in all severely disabled patients. The mean follow-
up time is now 18 ± 9 weeks (range 8 to 44). Eight
patients died 4 to 12 weeks after the procedure; all but
one were more than 80 years of age and were in func-
tional class HI or IV before valvuloplasty. Improvement
noted before hospitaldischarge wassustained and marked
in most of the remaining patients. Repeat catheterization
performed in 12 patients, 4 to 24 weeks later, confirmed
a stable hemodynamic improvement.
These results suggest that aortic valvuloplasty could
become a relatively simple, safe, low cost possible ther-
apeutic procedure in patients who are not surgical can-
didates or in patients, mostly elderly, who are considered
to be at high risk for valve replacement.
a Am Coli CardioI1987;9:381-6)
few cases of percutaneous balloon dilation of rheumatic
mitral stenosis have been published (\2-15).
We have considered the extension of the procedure to
adult severe calcific aortic stenosis, because this method
could offer a new therapeutic approach in a large number
of high risk surgical candidates. mostly elderly, in whom
valve replacement is often deferred. Percutaneous translu-
minal balloon valvuloplasty was performed first as an ul-
timate lifesaving attempt in three elderly patients with very
severe life-threatening aortic stenosis for whom surgical
valve replacement was definitely rejected because of an
unacceptably high risk due to both old age and major left
0735-1097/87/$3.50
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ventricular dysfunction (16). After these first encouraging
results, indications were extended to additional patients at
high operative risk. The technical approach is now well
mastered and the procedure has become routinely applied
in our department. Elderly patients, particularly those with
marked cardiac failure, are mainly considered. However,
valvuloplasty has also been performed in younger patients,
when open heart surgery was contraindicated or when sur-
gical intervention was refused.
Methods
Patient selection. This series included 92 patients, 43
men and 49 women. The mean patient age was 75 ± II
years (range 35 to 91). Thirty-five patients were more than
80 years, 34 between 70 and 80 years and 23 less than 70
years old. Most of them had severe clinical impairment; 66
had New York Heart Association functional class III or IV
dyspnea due to heart failure. In this group, 20 also had
syncopal attacks and 17 severe angina pectoris occurring on
minimal activity. Two of them had had a myocardial in-
farction II and 15 days, respectively, before balloon val-
vuloplasty and 22 had an episode of acute pulmonary edema
in the preceding month. Twenty-six patients had less severe
symptomsof heart failure (functionalclass I or II) but among
them, seven presented with syncopal attacks and four with
severe angina. The remaining 15 patients had no alarming
symptoms but clinical signs of tight aortic stenosis and in-
Figure 1. Correct position of a 15 mm balloon across the stenotic
aortic valve during early (left panel) and full (right panel) infla-
tion. Indentation from the calcified stenotic valve is clearly seen
at early inflation and disappears at full inflation.
dexes of progressive left ventricular dysfunction. Alto-
gether, considering advanced aged, high degree of heart
failure and poor clinical condition, 42 patients could not be
considered for valve replacement, balloon valvuloplasty thus
being the only possible treatment.
The diagnosis of aortic valve stenosis was assessed on
clinical, phonocardiographic and echocardiographic data.
All patients had given oral consent for the valvuloplasty
procedure to be performed immediately after hemodynamic
confirmation of severe aortic valve stenosis.
Valvuloplasty procedure. The procedure started after
intravenous injectionof 0.5 mg atropine, 50 mg clorazepate
dipotassium (Tranxene) and 100 IU/kg heparin; the dose of
heparin was limited to 50 IU/kg in the last 60 patients. A
Swan-Ganz thermodilution catheter was inserted into the
pulmonary artery through the right femoral vein to record
right heart and pulmonary pressuresand measurethe cardiac
output. A catheter was inserted into the left femoral artery
to monitor the aortic blood pressure. Left heart catheteriza-
tion was done 82 times by the femoral route and 10 times
after brachial artery cutdown at the elbow. A supravalvular
aortogram was performed to assess the severity of aortic
insufficiency before valvuloplasty. The aortic orifice was
crossed with a 7F Bourassa or Sones catheter, depending
on the access route. In two other patients who are not in-
cluded in this series, we did not succeed in crossing the
valve by either routeand we had to give up the valvuloplasty
attempt. Left ventricular and aortic pressures were simul-
taneously recorded to measure the peak to peak systolic
gradient. A selective right anterior oblique angiogram of
the left ventricle was then performed to assess left ventric-
ular function.
The left ventricular catheter was exchanged for the first
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Figure 2. Example of simultaneous recording of left ventricular
and aortic pressures: before dilation (0) and after dilation with 15
mm (I). 18 mm (2) and 20 mm (3) balloons. The transvalvular
peak systolic pressure gradient progressively decreased from
100 g to 40 mm Hg.
Tolerance of the procedure. Clinical and hemodynamic
tolerance of the inflation procedure was surprisingly good.
One patient collapsed for a few seconds at the end of a first
20 second inflation; subsequent inflations lasted 10 seconds
only and were well tolerated. In 16 other cases, the systolic
aortic pressure rapidly fell to below 60 mm Hg with balloon
inflation. necessitating rapid deflation after 5 to 10 seconds
and withdrawal of the balloon into the aorta; the aortic
pressure returned immediately to normal. In 14 of these 17
patients, left ventricular function was markedly impaired
(ejection fraction less than 40%). In all the other cases, a
moderate decrease in systolic blood pressure was noted,
from 138 ± 22 to 91 ± 27 mm Hg on average, never to
less than 60 mm Hg, suggesting that the obstruction caused
by the inflated balloon was incomplete. In 10 patients, this
was confirmed by aortic root angiography during balloon
as mean ± SD. Statistical analysis was performed with
Student's t test as applied to paired values.
Clinical evaluation. The clinical status was assessed on
the basis of dyspnea class, and the frequency of syncope
and angina pectoris before and after valvuloplasty. The post-
valvuloplasty changes could be easily assessed during the
hospital stay in those patients who were most severely in-
capacitated before the procedure.
After discharge. the patients were followed up by the
staff of our department, either directly (two-thirds of the
patients) or by telephone inquiry, by calling the patients
themselves, their personal physician and their cardiologist.
dilation catheter over a 270 cm, 0.035 inch (0.89 ern) or
0.038 inch (0.97 cm) guidewire (USC!). We used 9F balloon
catheters designed for dilation of congenital valve stenosis.
The balloons were 30 mm long and had an inflated diameter
of 8, 10, 12, 15, 18 or 20 rnm, according to the model.
Two radiopaque markers gave the positions of the proximal
and distal ends of the balloon, thus ensuring correct trans-
valvular positioning (Fig. I). In the first 20 dilations, a
pressure-controlled hand pump was used to inject 10 ml of
a 50/50 mixture of contrast medium and 0.9% saline solution
at 5 to 7 atm inflation pressure. However, rupture was un-
predictable and appeared independent of the inflation pres-
sure. Thereafter, inflation pressure was not monitored. The
duration of inflation was initially limited to less than 30
seconds but was subsequently usually increased to 60 or
more seconds (mean 80). The soft-tipped 270 cm guidewire
was curved to avoid myocardial perforation, and was left
in the ventricular cavity during inflation to stabilize the
balloon in its transvalvular position.
In the first six patients, the initial dilation was performed
with an 8 mm diameter balloon, then exchanged for 10 and
12 mm sizes. Subsequently, the initial dilation has been
performed with a 15 mm diameter balloon which has always
passed easily across the aortic valve even in cases of severe
stenosis. After three inflations, the 15 mm balloon was
exchanged for an 18 mm and then a 20 mm balloon if
necessary. The aim of the procedure was to decrease the
transvalvular gradient to 40 mm Hg or less, a result con-
sidered satisfactory (Fig. 2). However, tortuosity of the iliac
artery or aorta impeded balloon catheter exchanging pro-
cedures in 16 patients, and consequently the largest balloon
size used was IS mm in 4 patients and 18 mm in 12. An
electrocardiogram and aortic pressure were continously re-
corded and monitored during the procedure. Ventricular and
aortic pressures were recorded simultaneously after each
inflation series to assess the residual transvalvular gradient.
At the end of the procedure, cardiac output was measured
and selective left ventricular and supravalvular aortic an-
giograms were done to assess left ventricular function, valve
motion and residual aortic regurgitation. Coronary artery
angiography was also performed if anginal pain had been
the main presenting clinical symptom. Protamine sulfate
was used to reverse heparin effect before femoral compres-
sion or brachial artery suture. A surgical team was on standby
for the few first patients only, in case of an acute compli-
cation.
Hemodynamic evaluation. The effects of valvuloplasty
were immediately evaluated by comparison of the left ven-
tricular-aortic peak to peak systolic gradient and aortic valve
area (17), before and after the procedure. Left ventricular
function was assessed by the ejection fraction. Furthermore.
late hemodynamic results were assessed several weeks or
months after the valvuloplasty in 12 patients who consented
to a repeat cardiac catheterization. All data are expressed
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Figure 3. Late hemodynamic reevaluation in 10 patients: aortic
valve area before (B) and immediately after (C) dilation and on
repeat cardiac catheterization at 14 weeks (late C). Improvement
in valve area remained unchanged on late restudy.
follow-up is now 18 ± 9 weeks (range 8 to 44). Eight
patients died between the third week and fourth month after
discharge. Only one, a 68 year old woman, could have been
considered for surgery but she had refused the intervention;
she died from an ill-defined condition. The others could not
have been considered surgical candidates, because of both
age greater than 80 years (range 81 to 88) and major left
ventricular dysfunction. The cause of death was terminal
heart failure in one patient, pulmonary infection in four
patients and myocardial infarction in two cases occurring I
and 3 months, respectively, after discharge. These two last
patients had severe multi vessel coronary disease on arteri-
ography and both had had a previous infarction II and 15
days, respectively, before valvuloplasty.
The clinical improvement was sustained and marked in
most of the 81 remaining patients: 73 (90%) were in func-
tional class I or II, with normalization of physical activities
for their age, whereas 8 remained in class III to IV. There
was no recurrence of syncope and lessening of angina per-
sisted.
Late hemodynamic reevaluation. A repeat catheter-
ization could be performed in 12 patients an average of 14
weeks (range 4 to 24) after the valvuloplasty. The good
results in gradient reduction observed after dilation (from
74 ± 20 to 39 ± 10 mm Hg) remained unchanged (45 ±
12 mm Hg, p = NS). Aortic valve area could be compared
in only 10 patients. It had increased from 0.53 ± 0.18 to
0.76 ± 0.27 ern? after dilation and remained satisfactorily
increased to 0.75 ± 0.25 ern? (p = NS) (Fig. 3). Eight of
these 10 patients had a left ventricular angiogram before
and after the valvuloplasty and at late follow-up. The ejec-
tion fraction, which was unchanged after dilation, was clearly
increased on late evaluation (53 ± 12 to 61 ± 14%, P <
0.05).
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inflation which showed marked regurgitation into the left
ventricle. There was no complication directly attributable
to the balloon inflations, and no clinical evidence of calcium
embolic phenomena.
Hemodynamic and angiographic results. The mean
duration of the procedure was 75 minutes. The left ven-
tricular-aortic peak to peak systolic gradient decreased from
75 ± 26 to 30 ± 13 mm Hg (p < 0.001) after valvuloplasty;
the residual gradient was less than 40 mm Hg in 78 cases.
Mean aortic valve area grossly doubled, from 0.49 ± 0.17
to 0.93 ± 0.36 ern? (p < 0.001). After dilation, aortic valve
area was greater than I crrr' in 29 patients; in only 19 patients
did it remain less than 0.7 crrr'.
Eighty-six patients had initial selective left ventricular
angiography; the mean ejection fraction was 49 ± 16%. In
70 cases, a left ventricular angiogram was obtained im-
mediately after dilation; the ejection fraction increased from
48 ± 16 to 51 ± 16% (p < 0.01). In the 26 patients in
whom ejection fraction was initially below 40%, it increased
from 31 ± 6% to 35 ± 4% (p < 0.02).
Valvuloplasty resulted in moderately severe (grade 3)
aortic regurgitation in two patients. After valvuloplasty, 52
patients had trace or mild (grade 1) regurgitation that was
nearly unchanged from that before dilation in 40 patients
and was new in 12.
In-hospital course. The mean hospital stay was 6 days.
Immediate clinical improvement was remarkable in severely
disabled patients. In the 66 patients initially in functional
class III to IV, dyspnea was rapidly and often dramatically
lessened: 58 patients were in functional class I to II at
discharge, enabling them to resume normal physical activ-
ities for their age. No patient who underwent valvuloplasty
complained of angina during walking and climbing stairs
before discharge. There was no recurrence of syncope.
Three patients died shortly after the procedure. A 78
year old patient died 24 hours after valvuloplasty of un-
controllable internal hemorrhage. In this patient, the cath-
eterization had been made difficult by extreme iliac tor-
tuosities; hemorrhage due to vascular perforation was
suspected. Another patient, aged 83, developed subacute
ischemia of the leg after an unsuccessful attempt to pass the
dilation catheter because of severe atherosclerosis of the
iliac arteries and the aorta. He died 3 days later of gram-
negative septicemia. A third patient, an 85 year old woman,
died of acute pulmonary edema 4 hours after incomplete
valvuloplasty. The initial trans valvular gradient was ex-
tremely high (190 mm Hg) and was reduced to only 90 mm
Hg after dilation with a 15 mm balloon, further exchange
to a higher balloon size being impossible.
Three patients developed a false aneurysm of the femoral
artery and one patient had an arteriovenous shunt requiring
surgical correction.
Follow-up. Accurate information on the clinical course
could be obtained for all patients. The mean duration of
lACC Vol. 9. No.2
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Discussion
Surgical valve replacement is a wellestablishedeffective
treatment of aortic stenosis, with a mortality rate in adults
of about 5% (18-21) . However, this risk increases in elderly
patients (21-23), and is much higher in patients with severe
left ventricular dysfunction in whom it can reach 20 to 25%
(21,24). Furthermore , additional factors such as severe
coronary disease. renal insufficiency or chronic pulmonary
disease, often combined with advanced age or left ventric-
ular failure, or both, may place the patient in a category in
whichsurgerycannot be consideredbecauseof unacceptable
risk. The results of our study show that percutaneous trans-
luminal aortic valvuloplasty in adult patients with calcific
aortic stenosis is feasible, and that good results can be ob-
tained despite the usual considerable changes in valve struc-
ture due to the degenerative process.
Although the exact mechanism of the efficacy of the bal-
loon dilation is largely unknown . the effect of aortic val-
vuloplasty could be the result of flattening or folding of the
thickened calcified valvular leaflets, and in some cases sep-
aration of fused commissures, althoughcommissural fusion
is not the main feature of aortic stenosis in the elderly adult
(25). The efficacy of the procedure could also be due to
fractureof thecalcifiedframeof the valvularcusps, reducing
calcifications to separate fragments and enabling the valve
to recover a certain degree of suppleness. The gross ana-
tomic changes are probably moderate, but it is well known
that a small increase in valve orifice area can dramatically
reduce the transvalvulargradient and improve flow (21). In
our series, the aortic orifice area increased from 0.49 to
0.93 ern? whichrepresents a remarkable change in the hemo-
dynamic situation and easily explains the considerable clin-
ical improvement.
Feasibility and tolerance of balloon valvuloplasty.
Technically, the procedure is relatively simple and can be
done in any experienced catheterization laboratory. Al-
thoughtheaortic valve isoftenhard to cross inadultcalcified
aortic stenosis, the insertion of the dilation catheters into
the left ventricular cavity over a guidewire and the trans-
valvular positioning of the balloon were most often easily
accomplished. Ballooninflations were usually well tolerated
by the patient and often could be sustained for several min-
utes. Transient circulatory arrest seems to be a risk in only
a few patients with markedlydepressed left ventricular func-
tion and is announced by a rapid fall in blood pressure .
quickly relieved in all cases by simultaneously deflating the
balloon and pulling the catheter back into the aorta. Such
a brief and controlled phase of profound hypotension during
balloon inflation, which in no case lasted more than a few
seconds. was unlikely to result in clinical complications and
never appeared to be life threatening. In fact. in the vast
majority of cases, the catheters did not totally occlude the
left ventricularoutflowduring systole, probably because of
widening of the commissures by the inflated balloon, or
because of the irregular shape of the aortic orifice, or both.
Hemodynamic and clinical improvement. The in-
crease in valve opening is demonstrated by the decrease in
the left ventricular-aortic pressure gradient and by the in-
crease in calculated aortic valve area that were obtained in
all cases. The efficiency of the dilation is confirmed by the
dramatically rapidclinical improvement of the mostseverely
disabled patients. during the first few days after dilation.
This clinical improvement was unchanged in almost all the
patients after4 months(average) of follow-up,even in those
followed up for more than 6 months.
Although only 12 patients could have repeat catheteriza-
tion. the hemodynamic improvement was confirmed as sta-
ble with a mean follow-up of 14 weeks. The gradient and
the aortic valve area remained improved and unchanged
when compared with immediate postvalvuloplasty data. This
explained the marked sustained clinical improvement. De-
spite the small numberof late control data, these short-term
hemodynamic results are very encouraging. However, they
need to be confirmed by further hemodynamic reevaluation .
Complications. There was no complication directly re-
lated to the balloon inflations; in particular, there was no
evidence of liberation of calcific debris even though all but
I of our 82 patients had a massively calcified valve. One
explanation may be that the calcifications are usually en-
cased withinthe valve leaflets and are not easily freedduring
the procedure. Late fatal myocardial infarction in two pa-
tients with severe coronary artery disease and previous in-
farction was unlikely to have been a result of the liberation
of calcifi c or valvular debris.
Two of the three early deaths were clearly related to the
use of a stiff catheter in tortuous and atherosclerotic vessels
in elderlypatients. The third death resultedfrom insufficient
valve dilation in a patient with extremely severe aortic ste-
nosis, marked left ventricular dysfunction and refractory
pulmonary edema before the procedure . However, consid-
ering these three early deaths, the mortality rate of aortic
valvuloplasty was 3.2%. which is much lower than that in
comparable series of patients operated on for valve replace-
ment. Our 69 patients older than 70 years had a mean age
of 79. which is clearly higher than that in most published
surgical series. Although postsurgical deaths are counted up
to I month after valve replacement because of the long
recovery period, it would not be logical to include in the
aortic valvuloplasty mortality rate the patients who died
several weeks after discharge. becausethe postvalvuloplasty
recovery period is only 3 or 4 days.
Conclusions. It is too early to predict the clinical in-
dications and limitations of percutaneous balloon valvulo-
plasty for the treatment of adult calcific aortic stenosis.
Although our results are most encouraging. the follow-up
period is still too short and the question of long-term results
needs to be addressed. Nevertheless, the stability of the
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functional improvement in most patients with a mean fol-
low-up time of 4 months (up to 10 months for the first
patient) and the promising data of the late hemodynamic
reevaluations are good reasons to expect lasting results.
Despite the fact that the economic impact of valvuloplasty
will become known only after long-term follow-up, it can
be pointed out that the procedure requires only standard
cardiac catheterization, low cost materials and 5 or 6 days
of hospital stay, with immediateresumption of a normal life
style.
These results suggest that aortic valvuloplasty can be
considered as a new possibly effective treatment in patients
who are not surgical candidates, mainly because of unac-
ceptably high surgical risk. It has been a lifesaving proce-
dure in a number of such patients of our series. The method
could also become a preliminary therapeutic attempt in a
large subgroup of patients in whom surgery involves high
risks. Further long-term studies, possibly randomized against
surgery in youngerpatients, are needed to indicatethe future
application of this relatively simple, low risk and low cost
method.
We thank Nicholas Moore, MD and P. Kleaveland. MD for their help in
the translation of the manuscript.
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